1-14 of 14
Eugene D. Kwon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer

Henan Zhang, Jacob J. Orme, Feven Abraha, B.J. Stish, Val J. Lowe, Fabrice Lucien, Erik J. Tryggestad, Michael S. Bold, Lance C. Pagliaro, C. Richard Choo, Debra H. Brinkmann, Matthew J. Iott, Brian J. Davis, J. Fernando Quevedo, William S. Harmsen, Brian A. Costello, Geoffrey B. Johnson, Mark A. Nathan, Kenneth R. Olivier, Thomas M. Pisansky, Eugene D. Kwon, Haidong Dong, Sean S. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6376–6383.
https://doi.org/10.1158/1078-0432.CCR-21-2510
Published: 01 December 2021
View article titled, Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors

Jeanette E. Eckel-Passow, Daniel J. Serie, John C. Cheville, Thai H. Ho, Sue M. Harrington, Tracy Hilton, Christine Lohse, Amanda Shreders, Payal Kapur, James Brugarolas, R Houston Thompson, Bradley C. Leibovich, Eugene D. Kwon, Richard W. Joseph, Alexander S. Parker
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): 10.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-10
Published: 03 January 2016
View article titled, Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors
Journal Articles

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Michael P. Gustafson, Yi Lin, Jonathan S. Bleeker, Deepti Warad, Matthew K. Tollefson, Paul L. Crispen, Peggy A. Bulur, Susan M. Harrington, Rebecca R. Laborde, Dennis A. Gastineau, Bradley C. Leibovich, John C. Cheville, Eugene D. Kwon, Allan B. Dietz
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4224–4233.
https://doi.org/10.1158/1078-0432.CCR-15-0260
Published: 14 September 2015
View article titled, Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
Open the PDF for Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma

David F. McDermott, Su-Chun Cheng, Sabina Signoretti, Kim A. Margolin, Joseph I. Clark, Jeffrey A. Sosman, Janice P. Dutcher, Theodore F. Logan, Brendan D. Curti, Marc S. Ernstoff, Leonard Appleman, Michael K.K. Wong, Nikhil I. Khushalani, Leslie Oleksowicz, Ulka N. Vaishampayan, James W. Mier, David J. Panka, Rupal S. Bhatt, Alexandra S. Bailey, Bradley C. Leibovich, Eugene D. Kwon, Fairooz F. Kabbinavar, Arie S. Belldegrun, Robert A. Figlin, Allan J. Pantuck, Meredith M. Regan, Michael B. Atkins
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (3): 561–568.
https://doi.org/10.1158/1078-0432.CCR-14-1520
Published: 01 February 2015
View article titled, The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma
Open the PDF for The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma in another window
Journal Articles

Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma

Xavier Frigola, Brant A. Inman, Christine M. Lohse, Christopher J. Krco, John C. Cheville, R. Houston Thompson, Bradley Leibovich, Michael L. Blute, Haidong Dong, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1915–1923.
https://doi.org/10.1158/1078-0432.CCR-10-0250
Published: 31 March 2011
View article titled, Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma
Open the PDF for Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases

Grant Chavin, Yuri Sheinin, Paul L. Crispen, Stephen A. Boorjian, Timothy J. Roth, Laureano Rangel, Michael L. Blute, Thomas J. Sebo, Don J. Tindall, Eugene D. Kwon, R. Jeffrey Karnes
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2174–2180.
https://doi.org/10.1158/1078-0432.CCR-08-2262
Published: 16 March 2009
View article titled, Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases
Open the PDF for Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases in another window
Journal Articles

Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, R. Houston Thompson, Stephen A. Boorjian, Haidong Dong, Bradley C. Leibovich, Michael L. Blute, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5150–5157.
https://doi.org/10.1158/1078-0432.CCR-08-0536
Published: 12 August 2008
View article titled, Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma
Open the PDF for Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma in another window
Journal Articles

T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival

Stephen A. Boorjian, Yuri Sheinin, Paul L. Crispen, Sara A. Farmer, Christine M. Lohse, Susan M. Kuntz, Bradley C. Leibovich, Eugene D. Kwon, Igor Frank
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4800–4808.
https://doi.org/10.1158/1078-0432.CCR-08-0731
Published: 01 August 2008
View article titled, T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival
Open the PDF for T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival in another window
Includes: Supplementary data
Journal Articles

Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma

Sameer A. Siddiqui, Xavier Frigola, Sandra Bonne-Annee, Maria Mercader, Susan M. Kuntz, Amy E. Krambeck, Shomik Sengupta, Haidong Dong, John C. Cheville, Christine M. Lohse, Christopher J. Krco, W. Scott Webster, Bradley C. Leibovich, Michael L. Blute, Keith L. Knutson, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 2075–2081.
https://doi.org/10.1158/1078-0432.CCR-06-2139
Published: 02 April 2007
View article titled, Tumor-Infiltrating Foxp3<sup>−</sup>CD4<sup>+</sup>CD25<sup>+</sup> T Cells Predict Poor Survival in Renal Cell Carcinoma
Open the PDF for Tumor-Infiltrating Foxp3<sup>−</sup>CD4<sup>+</sup>CD25<sup>+</sup> T Cells Predict Poor Survival in Renal Cell Carcinoma in another window
Journal Articles

Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma

Amy E. Krambeck, Haidong Dong, R. Houston Thompson, Susan M. Kuntz, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute, Thomas J. Sebo, John C. Cheville, Alexander S. Parker, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1749–1756.
https://doi.org/10.1158/1078-0432.CCR-06-2129
Published: 15 March 2007
View article titled, Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma
Open the PDF for Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma in another window
Journal Articles

PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

R. Houston Thompson, Haidong Dong, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1757–1761.
https://doi.org/10.1158/1078-0432.CCR-06-2599
Published: 15 March 2007
View article titled, PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
Open the PDF for PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma in another window
Journal Articles

Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference

Michael B. Atkins, Marc S. Ernstoff, Robert A. Figlin, Keith T. Flaherty, Daniel J. George, William G. Kaelin, Jr., Eugene D. Kwon, Towia A. Libermann, W. Marston Linehan, David F. McDermott, Augusto C. Ochoa, Allan J. Pantuck, Brian I. Rini, Mark A. Rosen, Jeffrey A. Sosman, Vikas P. Sukhatme, Johannes W. Vieweg, Christopher G. Wood, Laura King
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 667s–670s.
https://doi.org/10.1158/1078-0432.CCR-06-2231
Published: 25 January 2007
View article titled, Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference
Open the PDF for Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference in another window
Journal Articles

Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy

R. Houston Thompson, Haidong Dong, Eugene D. Kwon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 709s–715s.
https://doi.org/10.1158/1078-0432.CCR-06-1868
Published: 25 January 2007
View article titled, Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
Open the PDF for Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy in another window
Journal Articles

Clinical Significance of Defective Dendritic Cell Differentiation in Cancer

Bond Almand, John R. Resser, Brian Lindman, Sorena Nadaf, Joseph I. Clark, Eugene D. Kwon, David P. Carbone, Dmitry I. Gabrilovich
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1755–1766.
Published: 01 May 2000
View article titled, Clinical Significance of Defective Dendritic Cell Differentiation in Cancer
Open the PDF for Clinical Significance of Defective Dendritic Cell Differentiation in Cancer in another window